Coverage
-
November 03, 2020
More than 100 lawmakers from 34 states have lined up behind the U.S. Food and Drug Administration to urge the Fourth Circuit to pause an injunction that requires the agency to increase access to the so-called abortion pill, arguing that the U.S. Supreme Court's recent abortion ruling bolsters their case.
2 other articles on this case.
View all »